46
Views
13
CrossRef citations to date
0
Altmetric
Original Research

RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer

, , , &
Pages 5605-5619 | Published online: 23 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wei Huang, Jie Liu, Shanbiao Hu, Guangqing Shi, Zhong Yong, Jian Li, Juan Qiu, Yan Cao & Li Yuan. (2019) miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP. OncoTargets and Therapy 12, pages 10873-10884.
Read now

Articles from other publishers (12)

Massimo Papale, Giuseppe Stefano Netti, Giovanni Stallone & Elena Ranieri. (2022) Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools. Cancers 14:20, pages 5070.
Crossref
Silvia Vivarelli, Luca Falzone, Caterina Maria Grillo, Benjamin Bonavida, Claudia Crimi, Ignazio La Mantia & Massimo Libra. (2022) Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer. Cancers 14:4, pages 922.
Crossref
Yuhao Zou, Chenming Zhong, Zekai Hu & Shiwei Duan. (2021) MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis. Frontiers in Oncology 11.
Crossref
Wei Huang, Guangqing Shi, Zhong Yong, Jian Li, Juan Qiu, Yan Cao, Yongfeng Zhao & Li Yuan. (2020) RETRACTED ARTICLE: Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p. Cell Death & Disease 11:7.
Crossref
Begum Dariya, Gayathri Chalikonda, Afroz Alam & Ganji Purnachandra Nagaraju. 2020. Prognostic and Therapeutic Applications of RKIP in Cancer. Prognostic and Therapeutic Applications of RKIP in Cancer 415 434 .
Diana Cardoso-Carneiro, Ana Raquel-Cunha, Joana Pinheiro, Maria Gabriela-Freitas, Patrícia Fontão, Rui M. Reis & Olga Martinho. 2020. Prognostic and Therapeutic Applications of RKIP in Cancer. Prognostic and Therapeutic Applications of RKIP in Cancer 389 414 .
Theodoulakis Christofi & Apostolos Zaravinos. 2020. Prognostic and Therapeutic Applications of RKIP in Cancer. Prognostic and Therapeutic Applications of RKIP in Cancer 337 356 .
Martina Rama & Benjamin Bonavida. 2020. Prognostic and Therapeutic Applications of RKIP in Cancer. Prognostic and Therapeutic Applications of RKIP in Cancer 175 209 .
Fei Yao, Jinjing Yu, Yulin He, Jiaqi Liu, Huan Li, Qun Liu, Hui Long & Qingming Wu. (2019) Primary impact of Gli1 on radioresistance in esophageal cancer. Oncology Letters.
Crossref
Ana Raquel-Cunha, Diana Cardoso-Carneiro, Rui M. Reis & Olga Martinho. (2019) Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling. Cells 8:5, pages 442.
Crossref
Shidai Jin, Jing He, Jun Li, Renhua Guo, Yongqian Shu & Ping Liu. (2018) MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1. Thoracic Cancer 9:10, pages 1262-1270.
Crossref
Apostolos Zaravinos, Benjamin Bonavida, Ekaterini Chatzaki & Stavroula Baritaki. (2018) RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact. Cancers 10:9, pages 287.
Crossref